“Biostatistics Industry Career Panel: Leveraging Biostatistics, CBQG and HDS Degrees for Roles in Industry”
Career Panel | 2:15-3:45pm
Kresge G1- Snyder Auditorium – RSVP
Post-Career Panel Drop-in Refreshments & Visiting | 3:45-4:45pm
Kresge Atrium off Sebastian’s Café – RSVP
Submit questions for panelists (they will also answer questions asked at the event!)
AB ’97, PhD Biostatistics ’05
Chief Scientific Officer, Cytel
Yannis Jemiai is Chief Scientific Officer at Cytel Inc., a specialized provider of data-focused clinical research services and software solutions for the design and analysis of clinical trials, including industry standards East® and Xact®. In his role as CSO, Dr. Jemiai leads the product development and strategic consulting teams helping clients design innovative studies and answer tough questions about their data. His research interests include adaptive designs, modeling and simulation, quantitative decision-making, and causal inference.
PhD Biostatistics, 1998
VP of Biostatistics and Statistical Programming, resTORbio
resTORbio is a small biotech company working on medicines that target the biology of aging to prevent or treat aging-related diseases. In this role, Patti’s primary responsibilities include taking care of all statistical aspects of trial design and analyses of data generated from our clinical trials. She also makes sure that our analyses and datasets are compliant with regulatory requirements. Patti’s dissertation advisor was Dave Harrington.
SM CBQG ’19
Associate Scientist, Computational Biology, Wave Life Sciences
At Wave, Anthony employs a variety of machine learning-based methods to predict the efficacy of antisense oligonucleotides and identify novel sequence motifs driving compound efficiency. Furthermore, he designs and builds workflows that enable faster and more comprehensive design of new oligonucleotides.
SM CBQG ’19, PhD (Osaka University) ’11
Principal Scientist, Computational Biology
Pfizer Worldwide Research and Development
Dr. Nakashima applies her interdisciplinary expertise in population science and bioinformatics to develop computational methods and pipelines for discovery research projects. Currently, she leads computational analyses of DNA-sequencing, RNA-sequencing, and single-cell RNA sequencing. She works for different research units and departments including pharmacology science and rare disease at Pfizer.
SM60 Health Data Science ’19
Data Scientist II, Microsoft
Abi is a data scientist with Microsoft AI’s Development Acceleration Program. He facilitates data science efforts on Microsoft projects that integrate Artificial Intelligence capabilities into Microsoft products and services. Working out of the Cambridge, MA Research and Development Center of Microsoft, he is leveraging the data science training he received at Harvard to tackle practical data science challenges on a daily basis.
Amy (Stubbendick) Pace
Director of Biostatistics, Alexion
Amy Pace is currently Director of Biostatistics at Alexion, working in Neurology Clinical Development as the Biometrics lead on the Eculizumab Neuromyelitis Optica (NMO) program. Prior to Alexion, Amy worked at Biogen for almost 13 years across development and life cycle management in Multiple Sclerosis and Hemophilia and headed up the Worldwide Medical Biostatistics group. She received her ScD in Biostatistics from Harvard in 2003 and completed undergraduate studies at St. Olaf College in MN. (Amy has run the Boston Marathon 13 times!)